Fierce Pharma

MARCH 12, 2024

Despite Moderna’s efforts to prove its mRNA thesis beyond COVID-19 in 2023, the post-pandemic hangover took a toll on the company. | Despite Moderna’s efforts to prove its mRNA thesis beyond COVID-19 in 2023, the post-pandemic hangover took a heavy toll on the company. In turn, much of the company’s top brass—including CEO Stéphane Bancel—saw their total compensation fall for the year.

256

256

MedCity News

MARCH 12, 2024

At HIMSS, Google Cloud announced new AI features designed to assist providers, payers and any other healthcare organizations seeking to make better use of their clinical data.

Healthcare 142

Healthcare Healthcare 142

Fierce Pharma

MARCH 12, 2024

The antibody-drug conjugate (ADC) Adcetris has given Pfizer’s oncology department its first pivotal trial win from the legacy Seagen portfolio since the $43 billion merger. | The antibody-drug conjugate Adcetris has given Pfizer’s oncology department its first pivotal trial win from the legacy Seagen portfolio since the $43 billion merger.

249

249

Pharmaceutical Commerce

MARCH 12, 2024

A qualitative study explores how these drugs are impacting these patients’ lives, while digging deeper into the possibility of deprescribing, with insight from primary care physicians.

Physicians 111

Physicians Patients 111

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

MARCH 12, 2024

Acacia Pharmaceuticals is calling it quits on future testing of Nuplazid after a string of expansion efforts have come up short. | The company will not conduct any further clinical trials of the drug, which is currently approved to treat Parkinson’s disease psychosis. The decision comes after years of failed expansion bids in other uses.

Pharmaceutical 248

Pharmaceutical 248

Pharmaceutical Commerce

MARCH 12, 2024

A sit-down with Groovy Singh, CEO of Bright Green Corporation, who describes the waves in the global supply chain the company is making after being authorized to grow cannabis, along with cannabis-related products.

Manufacturing 105

Manufacturing 105

MedCity News

MARCH 12, 2024

With pimavanserin’s Phase 3 failure in schizophrenia, Acadia Pharmaceuticals said it will no longer run clinical trials for the drug, whose lone approval is for treating psychosis from Parkinson’s disease. The FDA previously rebuffed regulatory submissions for the drug in dementia and Alzheimer’s disease.

Pharmaceutical 108

Pharmaceutical FDA Biopharma Pharma 108

PharmaTech

MARCH 12, 2024

In an interview, Fabian Gerlinghaus of Cellares outlines a paradigm change in both hardware and software, regulatory expansions, and some positive cost outcomes for the CGT field.

98

98

European Pharmaceutical Review

MARCH 12, 2024

Data integrity is the term used to describe the accuracy, consistency and reliability of data throughout its lifecycle. In the pharmaceutical/life sciences industries, maintaining data integrity is crucial given its role in making critical decisions that shape outcomes from drug development to human health. What are three current key trends in data integrity?

Government 98

Government Pharma Ethics Training 98

pharmaphorum

MARCH 12, 2024

Up to 25,000 patients in England with ulcerative colitis are eligible for treatment with Pfizer’s Velsipity after NICE backed use of the drug on the same day as its MHRA approval.

Patients 100

Patients 100

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

European Pharmaceutical Review

MARCH 12, 2024

Coating is the oldest and last key unit operation in many tablet production processes. The function of the coating ranges from purely cosmetic improvements (brand recognition, better patient acceptance using API taste masking) to alterations of tablet release characteristics (control of the release profile and bioavailability of the API). Generally, the goal of coating is to generate a thin solid layer around the tablet core.

Distribution 98

Distribution Pharmaceutical Safety Pharma 98

pharmaphorum

MARCH 12, 2024

Healthcare systems need to address the impact of racial and ethnic biases in the design and use of medical devices, says an independent UK review.

Medical 107

Medical Healthcare Healthcare 107

MedCity News

MARCH 12, 2024

Four modest system improvements in the U.S. are assisting with valuing and activating people’s families and support networks in health care today.

Networking 105

Networking Patients 105

Pharmaceutical Technology

MARCH 12, 2024

TERN-701 is a BCR-ABL tyrosine-kinase inhibitor being studied in a Phase I study, with data expected in H2 this year.

FDA 105

FDA 105

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

pharmaphorum

MARCH 12, 2024

Sanofi says OX40L inhibitor amlitelimab could be a ‘best-in-class’ maintenance therapy for atopic dermatitis after reporting new phase 2b data

96

96

PharmaTimes

MARCH 12, 2024

Globally, cancer is currently the most leading cause of death due to disease among children

Leads 101

Leads 101

pharmaphorum

MARCH 12, 2024

Acadia Pharma has abandoned plans to develop Nuplazid for additional indications after the drug failed a phase 3 trial in schizophrenia.

Pharma 97

Pharma 97

PharmaVoice

MARCH 12, 2024

As colorectal deaths rise among younger people, a diagnostic could help pinpoint more patients.

Patients 98

Patients 98

Advertisement

PharmaTimes

MARCH 12, 2024

Between October 2023 and March 2024, the UKHSA said that 733 cases of measles were reported in England

88

88

Pharmaceutical Technology

MARCH 12, 2024

In an exclusive interview, Jaguar Health’s CEO discussed plans for the investigation of crofelemer in human and animal studies.

Pharmaceutical 75

Pharmaceutical 75

pharmaphorum

MARCH 12, 2024

Shares in Regulus Therapeutics leap after the company reports data with its microRNA-targeting drug in polycystic kidney disease, and files a $100m private placement.

59

59

Scott’s Directories

MARCH 12, 2024

In today’s healthcare industry, connecting efficiently with the right medical professionals is crucial. The physician directory by Nova Scotia is essential for healthcare professionals and organizations. By effectively using its filtering options, users can maximize the potential of this comprehensive database, which includes an extensive list of doctors in Nova Scotia.

Medical 52

Medical Doctors Physicians Healthcare Provider 52

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Clarify Health

MARCH 12, 2024

Providing high-quality care while keeping costs under control can often feel mutually exclusive. Health plans want to deliver the best possible care for their members, and that frequently takes a financial investment. But from a business perspective, health plans must find that balance between providing high-quality care at a lower cost for their members, and those that do will reap the benefits of better growth, improved member retention, and enhanced health plan profitability.

Healthcare 52

Healthcare Healthcare Management Leads 52

Evolve Your Success

MARCH 12, 2024

When Brooke Elliott got the chance to mentor medical sales reps to become the industry’s next-generation leaders, she found fulfillment in becoming a full-time coach. In her desire to help even more people, she decided to start BE Complete Coaching & Consulting. In this special episode for Women’s History Month and International Women’s Day, Brooke joins Samuel Adeyinka to share how she brings out the best in medical sales reps today.

Medical sales reps 52

Medical sales reps Medical sales Medical Sales 52

PharmExec

MARCH 12, 2024

Submission is based on positive results from the company’s Phase III QUASAR clinical trial, in which Tremfya (guselkumab) produced positive results treating moderately to severely active ulcerative colitis.

FDA 52

FDA 52

Evolve Your Success

MARCH 12, 2024

In this compelling episode of The Medical Sales Podcats, join Samuel Adeyinka and his special guest, Adam Mostafa , a titan in the field of healthcare sales and Managing Director of Business Development at TruVeta, as he delves into the data revolution transforming the medical device industry. With over a decade of rich experience that stretches from pharmaceuticals to medical devices and now healthcare data analytics, Adam provides unparalleled insights into the power of real-world evidence in

Pharmaceutical Sales 52

Pharmaceutical Sales Sales Pharmaceutical Healthcare 52

Advertisement

Distribution

PharmaVoice

MARCH 12, 2024

Although a regulatory delay for Eli Lilly’s donanemab in Alzheimer’s disease is a competitive setback, researchers have their eye on better drug development as a result.

Competition 52

Competition 52

Pharmaceutical Technology

MARCH 12, 2024

Enhance gene expression and reduce immune responses with Selecta Biosciences' patented method using viral vectors and nanocarriers attached to immunosuppressants. Learn more about this innovative approach for improved therapeutic outcomes.

52

52

Clarivate

MARCH 12, 2024

For the approximately 10% of biopharma candidates that actually manage to make it to clinical trials, many fail to achieve enough revenue once they reach the market to justify the R&D effort. In fact, one-third of drugs launched over a recent 10-year period fell short of sales expectations. Although some companies have the financial wherewithal and portfolio diversity to weather slower-than-expected sales trajectories or outright product failures, others are forced to sell off assets, seek a

Government 52

Government Marketing Physicians Biopharma 52

Pharmaceutical Technology

MARCH 12, 2024

Johnson & Johnson’s Tremfya is approved for plaque psoriasis and active psoriatic arthritis, with a label for ulcerative colitis now on the horizon.

52

52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales